Journal profile
Hong Kong Bulletin on Rheumatic Diseases
ISSN 2415-153X · Sciendo · Poland
Hong Kong Bulletin on Rheumatic Diseases: fully open access; review about 12 weeks (community reports); 0 articles in 2025.
Scope
Aims, scope and focus
Hong Kong Bulletin on Rheumatic Diseases is published by Sciendo. By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Pharmacovigilance and Adverse Drug Reactions and Biosimilars and Bioanalytical Methods, together about 35.3% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine18.8%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics8.2%
- Biosimilars and Bioanalytical MethodsImmunology and Microbiology8.2%
- Systemic Lupus Erythematosus ResearchMedicine5.9%
- Vasculitis and related conditionsMedicine5.9%
- Spondyloarthritis Studies and TreatmentsMedicine5.9%
- Autoimmune and Inflammatory Disorders ResearchMedicine4.7%
- Inflammatory Myopathies and DermatomyositisMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 3OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 39 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2025 | 0 | 0 | 1 |
| 2023 | 0 | 0 | 2 |
| 2022 | 0 | 0 | 3 |
| 2021 | 0 | 0 | 3 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Sciendo
- Country or region
- Poland
- Language
- English
- ISSN
- 2415-153X
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Hong Kong Bulletin on Rheumatic Diseases
How long does peer review take at Hong Kong Bulletin on Rheumatic Diseases?
Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is Hong Kong Bulletin on Rheumatic Diseases open access, and what is the APC?
Hong Kong Bulletin on Rheumatic Diseases is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .